As part of its overall plan of business, IGSM is a company, currently seeking solid acquisition candidates. The candidates must meet our criteria and are also willing to enter the public markets through our incubation process. This industry space presents not only an incredible financial opportunity, management plans raise future expectations of IGSM Group company goals and shareholder value significantly.

The Biotech Industry

According to Mr. Damien Conover, Morningstar's associate director of health care, he believes that there is a strong group of acquirers in Big Pharma that remain very motivated to do these acquisitions. They have a huge patent cliff coming up and they just don't have products in their own pipelines to offset that. Also, they have very strong balance sheets and cash flow generation so they have the means to acquire growth. IGSM Group is selective in choosing candidates with significant pipe-line and end market products.

Safe Harbor Statement

The statements in this release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact

IGSM GROUP INC.

Investor Relations

Email Contact